VAERS Explorer
Back to explore

Report #2884927

Received Feb 9, 2026

Hospitalized
A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
7

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (NO BRAND NAME)UNKNOWN MANUFACTURERUNKUNK—

Symptoms (4)

Blindness unilateralHerpes zosterOphthalmic herpes zosterVaccination failure

Symptom narrative

went into my eye from my face; lost most of the sight in that eye; still got Shingle/Went into my eye from my face; suspected vaccination failure; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: suspected vaccination failure) (serious criteria GSK medically significant), ophthalmic herpes zoster (Verbatim: went into my eye from my face) (serious criteria hospitalization and GSK medically significant), loss of vision (Verbatim: lost most of the sight in that eye) (serious criteria hospitalization and GSK medically significant) and facial herpes zoster (Verbatim: still got Shingle/Went into my eye from my face) (serious criteria hospitalization). The outcome of the vaccination failure, ophthalmic herpes zoster, loss of vision and facial herpes zoster were not reported. It was unknown if the reporter considered the vaccination failure, ophthalmic herpes zoster, loss of vision and facial herpes zoster to be related to Shingles vaccine. The company considered the vaccination failure, ophthalmic herpes zoster, loss of vision and facial herpes zoster to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 03-FEB-2026 This case was reported by a patient via interactive digital media. The patient stated that shingles were bad and spent a week in the hospita. The batch number was not provided and unable to contact the reporter. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of report.; Sender's Comments: A case of Vaccination failure, Ophthalmic herpes zoster, Blindness and Herpes zoster, unknown time after receiving Shingles vaccine, in a patient. Based on the available information a?possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.